Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Sung, Hyuna ^a   Jeon, Sujee ^b   Lee, Kyoung Mu ^c   Han, Sohee ^a   Song, Minkyo ^a   Choi, Ji Yeob ^a   Park, Sue K ^a   Yoo, Keun Young ^a   Noh, Dong Young ^a   Ahn, Sei Hyun ^d   Kang, Daehee ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Korea National Open University   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

Breast cancer; microRNA biogenesis pathway; Single nucleotide polymorphism; Survival

Indexed keywords

MICRORNA;

ADULT; AGED; AGO2 GENE; ALLELE; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DGCR8 GENE; DICER1 GENE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DROSHA GENE; FEMALE; FOLLOW UP; GEMIN4 GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HIGH RISK PATIENT; HIWI GENE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RNA SYNTHESIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARGONAUTE PROTEINS; BREAST NEOPLASMS; DEAD-BOX RNA HELICASES; FEMALE; FOLLOW-UP STUDIES; HAPLOTYPES; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBONUCLEASE III;

EID: 84861442401     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-195     Document Type: Article

References (39)

1. Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol 2009, 33:315-318. 10.1016/j.canep.2009.10.003, 19896917.
2. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011, 43:1-11. 10.4143/crt.2011.43.1.1, 3072529, 21509157.
3. Lee JH, Yim SH, Won YJ, Jung KW, Son BH, Lee HD, Lee ES, Yoo KY, Ahn SH, Shin HR. Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival. J Korean Med Sci 2007, 22(Suppl):S11-16. 10.3346/jkms.2007.22.S.S11, 2694389, 17923736.
4. Park SK, Kim Y, Kang D, Jung EJ, Yoo KY. Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea. J Breast Cancer 2011, 14:79-87. 10.4048/jbc.2011.14.2.79, 3148542, 21847401.
5. Hery C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 2008, 19:1187-1194. 10.1093/annonc/mdn025, 18325921.
6. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007, 25:5287-5312. 10.1200/JCO.2007.14.2364, 17954709.
7. Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, Caporaso NE, Chanock SJ, Hoover RN, Thomas G, Hunter DJ, Kraft P. A genome-wide association study of prognosis in breast cancer. Cancer Epidemiol Biomarkers Prev 2010, 19:1140-1143. 10.1158/1055-9965.EPI-10-0085, 2852476, 20332263.
8. Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 2010, 102:650-662. 10.1093/jnci/djq057, 2864289, 20308648.
9. Udler M, Maia AT, Cebrian A, Brown C, Greenberg D, Shah M, Caldas C, Dunning A, Easton D, Ponder B, Pharoah P. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol 2007, 25:3015-3023. 10.1200/JCO.2006.10.0099, 17634480.
10. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
11. Spizzo R, Nicoloso MS, Croce CM, Calin GA. SnapShot: MicroRNAs in Cancer. Cell 2009, 137:586-U204. 10.1016/j.cell.2009.04.040, 19410551.
12. O'Day E, Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010, 12:201. 10.1186/bcr2484, 2879559, 20346098.
13. Shi M, Liu D, Duan H, Shen B, Guo N. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 2010, 29:785-799. 10.1007/s10555-010-9265-9, 20938719.
14. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010, 10:389-402. 10.1038/nrc2867, 2950312, 20495573.
15. Lee HC, Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Jeon SW, Lee MH, Lim KH, Park JY, et al. Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer. J Cancer Res Clin Oncol 2010, 136:1073-1078. 10.1007/s00432-009-0754-6, 20044760.
16. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010, 31:1805-1812. 10.1093/carcin/bgq168, 2981457, 20732906.
17. Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 2010, 70:9765-9776. 10.1158/0008-5472.CAN-10-0130, 21118967.
18. Zhang X, Yang H, Lee JJ, Kim E, Lippman SM, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis 2010, 31:2118-2123. 10.1093/carcin/bgq177, 3105587, 20819778.
19. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139. 10.1038/nrm2632, 19165215.
20. Fuller-Pace FV, Ali S. The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators. Biochem Soc Trans 2008, 36:609-612. 10.1042/BST0360609, 18631126.
21. Hayes DF, Ethier S, Lippman ME. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Tr 2006, 100:237-238.
22. Sung H, Lee KM, Choi JY, Han S, Lee JY, Li L, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. Breast Cancer Res Treat 2011, 130:939-951. 10.1007/s10549-011-1656-2, 21766210.
23. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009, 37:W600-605. 10.1093/nar/gkp290, 2703930, 19417063.
24. Shaffer JP. Controlling the false discovery rate with constraints: the Newman-Keuls test revisited. Biom J 2007, 49:136-143. 10.1002/bimj.200610297, 17342955.
25. King DC, Taylor J, Elnitski L, Chiaromonte F, Miller W, Hardison RC. Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res 2005, 15:1051-1060. 10.1101/gr.3642605, 1182217, 16024817.
26. Adams BD, Claffey KP, White BA. Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology 2009, 150:14-23. 2630894, 18787018.
27. Kim MS, Oh JE, Kim YR, Park SW, Kang MR, Kim SS, Ahn CH, Yoo NJ, Lee SH. Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J Pathol 2010, 221:139-146. 10.1002/path.2683, 20198652.
28. Zhou Y, Chen L, Barlogie B, Stephens O, Wu X, Williams DR, Cartron MA, van Rhee F, Nair B, Waheed S, et al. High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc Natl Acad Sci U S A 2010, 107:7904-7909. 10.1073/pnas.0908441107, 2867889, 20385818.
29. Hutvagner G, Simard MJ. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 2008, 9:22-32. 10.1038/nrm2321, 18073770.
30. Liu X, Sun Y, Guo J, Ma H, Li J, Dong B, Jin G, Zhang J, Wu J, Meng L, Shou C. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int J Cancer 2006, 118:1922-1929. 10.1002/ijc.21575, 16287078.
31. Grochola LF, Greither T, Taubert H, Moller P, Knippschild U, Udelnow A, Henne-Bruns D, Wurl P. The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br J Cancer 2008, 99:1083-1088. 10.1038/sj.bjc.6604653, 2567072, 18781170.
32. He W, Wang Z, Wang Q, Fan Q, Shou C, Wang J, Giercksky KE, Nesland JM, Suo Z. Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. BMC Cancer 2009, 9:426. 10.1186/1471-2407-9-426, 2801519, 19995427.
33. Li S, Meng L, Zhu C, Wu L, Bai X, Wei J, Lu Y, Zhou J, Ma D. The universal overexpression of a cancer testis antigen hiwi is associated with cancer angiogenesis. Oncol Rep 2010, 23:1063-1068.
34. Sugito N, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Kurehara H, Ando T, Mori R, Takashima N, Ogawa R, Fujii Y. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006, 12:7322-7328. 10.1158/1078-0432.CCR-06-0515, 17121874.
35. Muralidhar B, Goldstein LD, Ng G, Winder DM, Palmer RD, Gooding EL, Barbosa-Morais NL, Mukherjee G, Thorne NP, Roberts I, et al. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 2007, 212:368-377. 10.1002/path.2179, 17471471.
36. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008, 359:2641-2650. 10.1056/NEJMoa0803785, 2710981, 19092150.
37. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, London WB, Chang CH, Yu AL. microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma. Cancer Res 2010, 70:7841-7850. 10.1158/0008-5472.CAN-10-0970, 20805302.
38. Dedes KJ, Natrajan R, Lambros MB, Geyer FC, Lopez-Garcia MA, Savage K, Jones RL, Reis-Filho JS. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur J Cancer 2011, 47:138-150. 10.1016/j.ejca.2010.08.007, 20832293.
39. Noh H, Hong S, Dong Z, Pan ZK, Jing Q, Huang S. Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression. Genes Cancer 2011, 2:140-150. 10.1177/1947601911408888, 3111246, 21779487.